CMS vs SPRY · P/E 20, $22.42B cap vs rev $89.1M
CMS Energy Corporation (CMS) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
CMS does not have a complete income-statement cache yet.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the CMS and SPRY stock pages for the full models.
Not investment advice.